Knowledge is the key to your health

Breast cancer is a risk that all women face. It is well known that mammography screening is the single most effective tool in early detection of breast cancer and has been proven to save lives. Reading mammograms is a difficult task, think of cancer as the needle in a haystack, they sometimes get overlooked. Studies have also shown that the double reading of mammograms can find more cancers.* MammoScreen® is an Artificial Intelligence system designed to help radiologists by providing a second assessment of your mammograms to reassure them nothing was missed.

*www.pubs.rsna.org/doi/10.1148/radiology.191.1.8134580

Positive outcomes when using AI in your radiology practice

What is MammoScreen®?

MammoScreen® uses the proprietary MammoScreen Score™ to provide at-a-glance level-of-suspicion scoring of your screening mammograms. The radiologist uses this technology as a second set of eyes; confirming either a negative or positive result in a specific area of interest (score 1 through 4, and 7 through 10), or questionable area of interest (score 5 and 6). The software points out areas with abnormalities and provides a score for each one indicating the level of suspicion. The radiologist takes this information into account during their review before deciding whether it is negative or requires a follow up examination such as additional imaging, ultrasound or a biopsy.

MammoScreen Score

Facts About Breast Cancer in the United States:

  • Breast cancer is the most common cancer globally as of 2021.
  • In 2021, an estimated 281,550 new cases of invasive breast cancer will be diagnosed in women in the U.S. as well as 48,290 new cases of non-invasive (in situ) breast cancer.
  • This year, an estimated 43,600 women will die from breast cancer in the U.S.
  • 1 in 8 women in the United States will develop breast cancer in her lifetime.
  • There are over 3.8 million breast cancer cases that are currently in or have finished treatment in the US.
  • Survival of breast cancer for at least 5 years after diagnosis ranges from more than 90% in high-income countries, to 66% in India and 40% in South Africa. *
  • Overall death rate from breast cancer decreased by 1% every year from 2013 to 2018. This is thought to be the result of treatment advances and earlier detection through screening.

 BreastCancer.org

* Breast cancer (who.int)

Visit our FAQ page for Patients